Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care
NCT ID: NCT05056701
Last Updated: 2024-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
400 participants
INTERVENTIONAL
2022-05-30
2037-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Regardless of its definition, preeclampsia is associated with an increased risk of obstetric events and, for the mother, an increased risk of developing chronic kidney disease (CKD), hypertension, diabetes and cardiovascular disease in the broad sense.
The relationship between preeclampsia and Chronic Kidney Disease is, however, complex and not fully understood.
Investigator proposes an interventional study to identify the diagnosis of Chronic Kidney Disease in patients who have developed an episode of Preeclampsia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients
NCT06059937
First-trimester Prediction of Preeclampsia
NCT02189148
Chronic Remote Ischemic Preconditioning as a Complement to Conventional Prenatal Care for Preeclampsia
NCT05564988
Association Between Pococyturia and Pre-eclampsia Severity
NCT03316391
Pre-Eclampsia And Growth Restriction: a Longitudinal Study
NCT02379832
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patient with preeclampsia
Patient meeting the preeclampsia criteria or one of its complications (eclampsia, HELLP syndrome) according to the ISSHP 2018 definitions within the last 5 years
annual follow-up during 10 years
an annual follow-up is carried out systematically for a total of 10 years in order to detect the subsequent occurrence of CKD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
annual follow-up during 10 years
an annual follow-up is carried out systematically for a total of 10 years in order to detect the subsequent occurrence of CKD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having signed the informed consent
* Person affiliated to social security
Exclusion Criteria
* Person deprived of liberty by judicial or administrative decision
* Person under forced psychiatric care
* Person subject to a legal protection measure
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier le Mans
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Angers
Angers, , France
Centre Hospitalier Du Mans
Le Mans, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHM-2020/S8/10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.